IP Library › Granted Patent US 7,858,611
Granted Patent B2
US 7,858,611 · App. 11/746,539 · Granted Dec 28, 2010

Neurogenesis by modulating angiotensin

Assignee: BrainCells Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,858,611
App. No.
11/746,539
Granted
Dec 28, 2010
Kind
B2
Abstract

The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The invention includes compositions and methods based on modulation angiotensin activity to stimulate or activate the formation of new nerve cells.

Claims (2)

1. A composition comprising, captopril in combination with or donepezil.

2. The composition of claim 1 , wherein the combination is in a single formulation.

Assignments (2)
SECURITY AGREEMENT Recorded Aug 9, 2011
From: BRAINCELLS, INC.
To: SILICON VALLEY BANK
Reel/Frame 026724/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2007
From: BARLOW, CAROLEE; CARTER, TODD A.; TREUNER, KAI; LORRAIN, KYM I.
To: BRAINCELLS, INC.
Reel/Frame 019654/0320 →
Continuity (3)
Provisional Application 6074685900 · May 9, 2006
Provisional Application 6080759400 · Jul 17, 2006
Related Publication 20080167291A1 · Jul 10, 2008